Trial Profile
Safety in terms of incidence and risk factors ocular hyper tension in patients with retinal vein occlusion, diabetic macular edema, postsurgical macular edema and uvietis who were treated with intravitreal dexamethasone implant (ozurdex): An observational, retrospective SAFODEX study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jan 2018
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Diabetic macular oedema; Retinal oedema; Retinal vein occlusion; Uveitis
- Focus Adverse reactions
- Acronyms SAFODEX
- 24 Jan 2018 New trial record